IBD Studies initiated and performed by the IBDnet

eSIBDC - Continuous monitoring meets Science

Principal Investigators: Gerhard Rogler, USZ

Vedolizumab first-line Study

Principal Investigators: Frank Seibold, Magendarmzentrum Bern

HARVEDO Trial

Principal Investigators: Michel Maillard, La Source

Registry to study the incidence, phenotype, risk factors and clinical course of inflammatory bowel disease in Zimbabwe

Principal Investigators: Benjamin Misselwitz, Insel

EoE-like syndrome with low-grade or absent esophageal eosinophilia – Molecular characterization of a new disease entity

Principal Investigator: Thomas Greuter, USZ

CX3CR1 biomarker Study

Principal Investigator: Michael Scharl, USZ

Swiss GWAS Study

Principal Investigators: Michael Scharl, USZ

Successfully Conducted Local Studies

ALERT: VAlidation of an 8‐item‐questionnaire predictive for a positive CaLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease

Principal Investigator: Thomas Rosemann, IHAMZ